Neuromedins U and S involvement in the regulation of the hypothalamo-pituitary-adrenal axis

Frontiers in Endocrinology

Volumn 3, Issue DEC, 2012, Pages

  Malendowicz, Ludwik K ^a   Ziolkowska, Agnieszka ^a   Rucinski, Marcin ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adrenal; Hypothalamus; Neuromedin S; Neuromedin U; Pituitary

Indexed keywords

EID: 84874401540     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2012.00156     Document Type: Review

References (103)

1. Austin, C., Lo, G., Nandha, K. A., Meleagros, L., and Bloom, S. R. (1995). Cloning and characterization of the cDNA encoding the human neuromedin U (NmU) precursor: NmU expression in the human gastrointestinal tract. J. Mol. Endocrinol. 14, 157-169.
2. Ballesta, J., Carlei, F., Bishop, A. E., Steel, J. H., Gibson, S. J., Fahey, M., et al. (1988). Occurrence and developmental pattern of neuromedin U-immunoreactive nerves in the gastrointestinal tract and brain of the rat. Neuroscience 25, 797-816.
3. Bornstein, S. R., Ehrhart-Bornstein, M., and Scherbaum, W. A. (1997). Morphological and functional studies of the paracrine interaction between cortex and medulla in the adrenal gland. Microsc. Res. Tech. 36, 520-533.
4. Brighton, P. J., Szekeres, P. G., and Willars, G. B. (2004). Neuromedin U and its receptors: structure, function, and physiological roles. Pharmacol. Rev. 56, 231-248.
5. Budhiraja, S., and Chugh, A. (2009). Neuromedin U: physiology, pharmacology and therapeutic potential. Fundam. Clin. Pharmacol. 23, 149-157.
6. Chen, T. B., Zhou, M., Walker, B., Harriot, P., Mori, K., Miyazato, M., et al. (2006). Structural and functionalanalogs of thenovel mammalian neuropeptide, neuromedin S (NmS), in the dermal venoms of Eurasian bombinid toads. Biochem. Biophys. Res. Commun. 345, 377-384.
7. Chu, C.-P., Xu, C.-J., Kannan, H., and Qui, D.-L. (2012). Corticotrophin-releasing factor inhibits neuromedin U mRNA expressing neuron in the rat hypothalamic paraventricular nucleus in vitro. Neurosci. Lett. 511, 79-83.
8. Cimini, V. (2003). Neuropeptides in anterior pituitary development. Int. J. Dev. Neurosci. 21, 291-301.
9. Cimini, V., Van Noorden, S., Timson, C. M., and Polak, J. M. (1993). Modulation of galanin and neuromedin U-like immunore-activity in rat corticotropes after alteration of endocrine status. Cell Tissue Res. 272, 137-146.
10. Conlon, J. M., Domin, J., Thim, L., DiMarzo, V., Morris, H. R., and Bloom, S. R. (1988). Primary structure of neuromedin U from the rat. J. Neurochem. 51, 988-991.
11. Denef, C. (2008). Paracrinicity: The story of 30 years of cellular pituitary crosstalk. J. Neuro endocrinol. 20, 1-70.
12. Domin, J., Benito-Orfila, M. A., Nandha, K. A., Aitken, A., and Bloom, S. R. (1992). The purification and sequence analysis of an avian neuromedin U. Regul. Pept. 41, 1-8.
13. Domin, J., Ghatei, M. A., Chochan, P., and Bloom, S. R. (1986). Characterization of neuromedin U-like immunoreactivity in rat, porcine, guinea pig and human tissue extracts using a specific radioimmunoassay.Biochem. Biophys. Res. Commun. 140, 1127-1134.
14. Domin, J., Ghatei, M. A., Chohan, P., and Bloom, S. R. (1987). Neuromedin U: a study of its distribution in the rat. Peptides 8, 779-784.
15. Domin, J., Polak, J. M., and Bloom, S. R. (1988). The distribution and biological effects of neuromedins B and U. Ann. N.Y.Acad. Sci. 547, 391-403.
16. Domin, J., Steel, J. H., Adolphus, N., Burrin, J. M., Leonhardt, U., Polak, J. M., et al. (1989). The anterior pituitary content of neuromedin U-like immunoreactivity is altered by thyrotrophin-releasing hormone and thyroid hormone status in the rat. J. Endocrinol. 122,471-476.
17. Domin, J., Yiangou, Y. G., Spokes, R. A., Aitken, A., Parmar, K. B., Chrysanthou, B. J., et al. (1989). The distribution, purification, and pharmacological action of an amphibian neuromedin U. J. Biol. Chem. 264, 20881-20885.
18. Ehrhart-Bornstein, M., Hinson, J. P., Bornstein, S. R., Scherbaum, W. A., and Vinson, G. P. (1998). Intraadrenal interactions in the regulation of adrenocortical steroido-genesis. Endocr. Rev. 19, 101-143.
19. Euer, N. I., Kaul, S., Deissler, H., Möbus, V. J., Zeilunger, R., and Weidle, U. H. (2005). Identification of L1CAM, Jagged2 and Neuromedin U as ovarian cancer-associated antigens. Oncol. Rep. 13, 375-387.
20. Fujii, R., Hosoya, M., Fukusumi, S., Kawamata, Y., Habata, Y., Hinuma, S., et al. (2000). Identification of neuromedin U as the cognate ligand of the orphan G-protein-coupled receptor FM-3. J. Biol. Chem. 275, 21068-21074.
21. Fukue, Y., Sato, T., Teranishi, H., Hanada, R., Takahashi, T., Nakashima, Y., et al. (2006). Regulation of gonadotropin secretion and puberty onset by neuromedin U. FEBS Lett. 580, 3485-3488.
22. Funes, S., Hedrick, J. A., Yang, S. J., Shan, L. X., Bayne, M., Monsma, F. J. Jr., et al. (2002). Cloning and characterization of murine neuromedin U receptors. Peptides 23,1607-1615.
23. Gartlon, J., Szekeres, P., Pullen, M., Sarau, H. M., Aiyar, N., Shabon, U., et al. (2004). Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats. Psychopharmacology (Berl.) 177, 1-14.
24. Graham, E. S., Turnbull, Y., Fotheringham, P., Nilaweera, K., Mercer, J. G., Morgan, P. J., et al. (2003). Neuromedin U and Neuromedin U receptor-2 expression in the mouse and rat hypothalamus: effects of nutritional status.J. Neurochem. 87,1165-1173.
25. Guan, X. M., Yu, H., Jiang, Q., Van Der Ploeg, L. H., and Liu, Q. (2001). Distribution of neuromedin U receptor subtype 2 mRNA in the rat brain. Brain Res. Gene Expr. Patterns 1, 1-4.
26. Hanada, R., Nakazato, M., Murakami, N., Sakihara, S., Yoshimatsu, H., Toshinai, K., et al. (2001). A role for neuromedin U in stress response. Biochem. Biophys. Res. Commun. 289, 225-228.
27. Hashimoto, T., Masui, H., Uchida, Y., Sakura,N., and Okimura, K. (1991). Agonistic and antagonistic activities of neuromedin U-8 analogs substituted with glycine or D-amino acid on contractile activity of chicken crop smooth muscle preparations. Chem. Pharm. Bull. 39, 2319-2322.
28. Hedrick, J. A., Morse, K., Shan, L. X., Qiao, X. D., Pang, L., Wang, S., et al. (2000). Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. Mol Pharmacol. 58, 870-875.
29. Honzawa, M., Sudok, T., Minamino, N., Tokyama, M., and Matsuo, H. (1987). Topographic localization of neuromedin U-like structures in the rat brain: an immunohistochemical study. Neuroscience 23, 1103-1122.
30. Hosoya, M., Moriya, T., Kawamata, Y., Ohkubo, S., Fujii, R., Matsui, H., et al. (2000). Identification and functional characterization of a novel subtype of neuromedin U receptor. J. Biol Chem. 275, 29528-29532.
31. Howard, A. D., Wang, R. P., Pong, S. S., Mellin, T. N., Strack, A., Guan, X. M., et al. (2000). Identification of receptors for neuromedin U and its role in feeding. Nature (Lond.) 406, 70-74.
32. Ida, T., Mori, K., Miyazato, M., Egi, Y., Abe, S., Nakahara, K., et al. (2005). Neuromedin s is a novel anorexi-genic hormone. Endocrinology 146, 4217-4223.
33. Ingallinella, P., Peier, A. M., Pocai, A., Di Marco, A., Desai, K., Zytko, K., et al. (2012). PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes. Bioorg. Med. Chem. 20,4751-4759.
34. Ivanov, T. R., Lawrence, C. B., Stanley, P. J., and Luckman, S. M. (2002). Evaluation of neuromedin U actions in energy homeostasis and pituitary function. Endocrinology 143, 3813-3821.
35. Jahan, S., Ahmed, S., and Shah, N. A. (2011). Role of neuromedin S in plasma testosterone and cortisol concentrations in male adult rhesus monkey (Macaca mulatta). Pak. J. Zool. 43, 147-153.
36. Jászberényi, M., Bagosi, Z., Thurzó, B., Földesi, I., and Telegdy, G. (2007). Endocrine and behavioral effects of neuromedin S. Horm. Behav. 52, 631-639.
37. Jethwa, P. H., Smith, K. L., Small, C. J., Abbott, C. R., Darch, S. J., Murphy, K. G., et al. (2006). Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat. Endocrinology 147, 2886-2892.
38. Kage, R., O'Harte, F., Thim, L., and Conlon, J. M. (1991). Rabbit neuromedin U-25: lack of conservation of a posttranslational processing site. Regul Pept. 33, 191-198.
39. Kamisoyama, H., Honda, K., Saneyasu, T., Sugahara, K., and Hasegawa, S. (2007). Central administration of neuromedin U suppresses food intake in chicks. Neurosci Lett. 420, 1-5.
40. Kangawa, K., Minamino, N., Fukuda, A., and Matsuo, H. (1983). Neuromedin K: a novel mammalian tachykinin identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 114,533-540.
41. Ketterer, K., Kong, B., Frank, D., Giese, N. A., Bauer, A., Hoheisel, J., et al. (2009). Neuromedin U is overex-pressed in pancreatic cancer and increases invasiveness via the hepa-tocyte growth factor c-Met pathway. Cancer Lett. 277, 72-81.
42. Kojima, M., Haruno, R., Nakazato, M., Date, Y., Murakami, N., Hanada, R., et al. (2000). Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). Biochem. Biophys. Res. Commun. 276, 435-438.
43. Korbonits, M., Morris, D. G., Nanzer, A., Kola, B., and Grossman, A. B. (2004). Role of regulatory factors in pituitary tumour formation. Front. Horm. Res. 32, 63-95.
44. Lee, W. H., Liu, S. B., Shen, J. H., Jin, Y., Lai, R., and Zhang, Y. (2005). Identification and molecular cloning of a novel neuromedin U analog from the skin secretions of toad Bombina maxima. Regul Pept. 129, 43-47.
45. Lo, G., Legon, S., Austin, C., Wallis, S., Wang, Z., and Bloom, S. R. (1992). Characterization of complementary DNA encoding the rat neuromedin U precursor. Mol Endocrinol. 6, 1538-1544.
46. Maderdrut, J. L., Lázár, G., Kozicz, T., and Merchenthaler, I. (1996). Distribution of neuromedin U-like immunoreactivity in the central nervous system of Rana esculenta. J. Comp. Neurol. 369, 438-450.
47. Malendowicz, L. K. (1998). Role of neuromedins in the regulation of adrenocortical function. Horm. Metab. Res. 30, 374-383.
48. Malendowicz, L. K., Andreis, P. G., Markowska, A., Nowak, M., Warchol, J. B., Neri, G., et al. (1994). Effects of neuromedin U-8 on the secretory activity of the rat adrenal cortex: evidence for an indirect action requiring the presence of the zona medullaris. Res. Exp. Med. (Berl.) 194, 69-79.
49. Malendowicz, L. K., Nussdorfer, G. G., Markowska, A., Tortorella, C., Nowak, M., and Warchol, J. B. (1994). Effects of neuromedin U (NMU)-8 on the rat hypothalamo-pituitary-adrenal axis. Evidence of a direct effect of NMU-8 on the adrenal gland. Neuropeptides 26, 47-53.
50. Malendowicz, L. K., Guidolin, D., Trejter, M., Rucinski, M., Porzionato, A., de Caro, R., et al. (2009). Neuromedin-U inhibits unilateral adrenalectomy-induced compensatory adrenal growth in the rat. Peptides 30, 935-939.
51. Malendowicz, L. K., and Markowska, A. (1994). Neuromedins and their involvement in the regulation of growth, structure and function of the adrenal cortex. Histol. Histopathol. 9,591-601.
52. Malendowicz, L. K., Nussdorfer, G. G., Nowak, K. W., and Mazzocchi, G. (1993). Effects of neuromedin U-8 on the rat pituitary-adrenocortical axis. In Vivo 7, 419-422.
53. Malendowicz, L. K., Rucinski, M., and Ziolkowska, A. (2013). "Neuromedins U/S," in Handbook of Biologically Active Peptides: Section XI Endocrine Peptides, ed A. Kastin (Amsterdam: Elsevier Inc.).
54. Mangold, C., Ksiazek, I., Yun, S. W., Berger, E., and Binkert, C. (2008). Distribution of neuromedin U binding sites in the rat CNS revealed by in vitro receptor autoradiography. Neuropeptides 42, 377-386.
55. Maruyama, K., Kaiya, H., Miyazato, M., Konno, N., Wakasugi, T., Uchiyama, M., et al. (2011). Isolation and characterisation of two cDNAs encoding the neuromedin U receptor from goldfish brain. J. Neuroendocrinol. 23,282-291.
56. Maruyama, K., Konno, N., Ishiguro, K., Wakasugi, T., Uchiyama, M., Shioda, S., et al. (2008). Isolation and characterisation of four cDNAs encoding neuromedin U (NMU) from the brain and gut of goldfish, and the inhibitory effect of a deduced NMU on food intake and locomotor activity. J. Neuroendocrinol. 20, 71-78.
57. Minamino, N., Kangawa, K., Fukuda, A., and Matsuo, H. (1984). Neuromedin L: a novel mammalian tachykinin identified in porcine spinal cord. Neuropeptides 4, 157-166.
58. Minamino, N., Kangawa, K., and Matsuo, H. (1984). Neuromedin C: a bombesin-like peptide identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 119, 14-20.
59. Minamino, N., Kangawa, K., and Matsuo, H. (1984). Neuromedin N: a novel neurotensin-like peptide identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 122,542-549.
60. Minamino, N., Kangawa, K., and Matsuo, H. (1983). Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord. Biochem. Biophys. Res. Commun. 114,541-548.
61. Minamino, N., Sudoh, T., Kangawa, K., and Matsuo, H. (1985). Neuromedins: novel smooth-muscle stimulating peptides identified in porcine spinal cord. Peptides 6, 245-248.
62. Mitchell, J. D., Maguire, J. J., and Davenport, A. P. (2009). Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S. Br. J Pharmacol. 158, 87-103.
63. Mitchell, J. D., Maguire, J. J., Kuc, R. E., and Davenport, A. P. (2009). Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system. Cardiovasc. Res. 81, 353-361.
64. Mori, K., Miyazato, M., Ida, T., Murakami, N., Serino, R., Ueta, Y., et al. (2005). Identification of neuromedin S and its possible role in the mammalian circadian oscillator system. EMBO J. 24, 325-335.
65. Mori, K., Miyazato, M., and Kangawa, K. (2008). Neuromedin S: discovery and functions. Results Probl. Cell Differ. 46,201-212.
66. Murphy, R., Turner, C. A., Furness, J. B., Parker, L., and Giraud, A. (1990). Isolation and microsequence analysis of a novel form of neuromedin-U from guinea-pig small-intestine. Peptides 11,613-617.
67. Nakahara, K., Katayama, T., Maruyama, K., Ida, T., Mori, K., Miyazato, M., et al. (2010). Comparison of feeding suppression by the anorexigenic hormones neuromedin U and neuromedin S in rats.J. Endocrinol. 207, 185-193.
68. Nakahara, K., Kojima, M., Hanada, R., Egi, Y., Ida, T., Miyazato, M., et al. (2004). Neuromedin U is involved in nociceptive reflexes and adaptation to environmental stimuli in mice. Biochem. Biophys. Res. Commun. 323, 615-620.
69. Nandha, K. A., Benito-Orfila, M. A., Smith, D. M., and Bloom, S. R. (1993). Characterization of the rat uterine neuromedin-U receptor. Endocrinology 133,482-486.
70. Neary, T., and Northcutt, R. G. (1983). Nuclear organization of the bullfrog diencephalon. J. Comp. Neurol. 213, 262-278.
71. Niimi, M., Murao, K., and Taminato, T. (2001). Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem. Endocrine 16, 201-206.
72. Nogueiras, R., Tovar, S., Mitchell, S. E., Barrett, P., Rayner, D. V., Dieguez, C., et al. (2006). Negative energy balance and leptin regulate neuromedin-U expression in the rat pars tuberalis. J. Endocrinol. 190, 545-553.
73. Nussdorfer, G. G. (1996). Paracrine control of adrenal cortical function by medullary chromaffin cells. Pharmacol. Rev. 48, 495-530.
74. O'Harte, F., Bockman, C. S., Abel, P. W., and Conlon, J. M. (1991). Isolation, structural characterization and pharmacological activity of dog neuromedin U. Peptides 12, 11-15.
75. O'Harte, F., Bockman, C. S., Zeng, W., Abel, P. W., Harvey, S., and Conlon, J. M. (1991). Primary structure and pharmacological activity of a nonapeptide related to neuromedin U isolated from chicken intestine. Peptides 12,809-812.
76. Ozaki, Y., Onaka, T., Nakazato, M., Saito, J., Kanemoto, K., Matsumoto, T., et al. (2002). Centrally administered neuromedin U activates neu-rosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraop-tic nuclei of rat. Endocrinology 143, 4320-4329.
77. Peier, A., Kosinski, J., Cox-York, K., Qian, Y., Desai, K., Feng, Y., et al. (2009). The antiobesity effects of centrally administered Neuromedin U and Neuromedin S are mediated predominantly by the Neuromedin U receptor 2 (NMUR2). Endocrinology 150, 3101-3109.
78. Qiu, D. L., Chu, C. P., Shirasaka, T., Nabekura, T., Kunitake, T., Kato, K., et al. (2003). Neuromedin U depolarizes rat hypothalamic paraventricular nucleus neurons in vitro by enhancing IH channel activity. J. Neurophysiol. 90, 843-850.
79. Qiu, D.-L., Chu, C.-P., Tsukino, H., Shirasaka, T., Nakao, H., Kato, K., et al. (2005). Neuromedin U receptor-2 mRNA and HCN channels mRNA expression in NMU-sensitive neurons in rat hypothalamicparaventricular nucleus. Neurosci. Lett. 374, 69-72.
80. Raddatz, R., Wilson, A. E., Artymyshyn, R., Bonini, J. A., Borowsky, B., Boteju, L. W., et al. (2000). Identification and characterization of two neuromedin U receptors differentially expressed in peripheral tissues and the central nervous system. J. Biol. Chem. 275, 32452-32459.
81. Rokkaku, K., Onaka, T., Okada, N., Ideno, J., Kawakami, A., Honda, K., et al. (2003). Neuromedin U facilitates oxytocin release from the pituitary via beta adrenoceptors. Neuroreport 14, 1997-2000.
82. Rucinski, M., Ziolkowska, A., Neri, G., Trejter, M., Zemleduch, T., Tyczewska, M., et al. (2007). Expression of neuromedins S and U and their receptors in the hypothalamus and endocrine glands of the rat. Int. J. Mol. Med. 20, 255-259.
83. Sakamoto, T., Mori, K., Miyazato, M., Kangawa, K., Sameshima, H., Nakahara, K., et al. (2008). Involvement of neuromedin S in the oxytocin release response to suckling stimulus. Biochem. Biophys. Res. Commun. 375, 49-53.
84. Sakamoto, T., Mori, K., Nakahara, K., Miyazato, M., Kangawa, K., Sameshima, H., et al. (2007). Neuromedin S exerts an antidiuretic action in rats. Biochem. Biophys. Res. Commun. 361,457-461.
85. Sakura, N., Ohta, S., Uchida, Y., Kurosawa, K., Okimura, K., and Hashimoto, T. (1991). Structure-activity relationships of rat neuromedin U for smooth muscle contraction. Chem. Pharm. Bull. 39, 2016-2020.
86. Salmon, A. L., Johnsen, A. H., Bienert, M., McMurray, G., Nandha, K. A., Bloom, S. R., et al. (2000). Isolation, structural characterization, and bioactivity of a novel neuromedin U analog from the defensive skin secretion of the Australasian tree frog, Litoria caerulea. J. Biol. Chem. 275, 4549-4554.
87. Sasaki, T., Shimizu, T., Wakiguchi, H., and Yokotani, K. (2008). Centrally administered neuromedin U elevates plasma adrenaline by brain prostanoid TP receptor-mediated mechanisms in rats. Eur. J.Pharmacol. 592,81-86.
88. Shan, L. X., Qiao, X. D., Crona, J. H., Behan, J., Wang, S., Laz, T., et al. (2000). Identification of a novel neuromedin U receptor subtype expressed in the central nervous system. J. Biol. Chem. 275, 39482-39486.
89. Shimizu, F., Matsuzaki, T., Iwasa, T., Minakuchi, M., Kuwahara, A., Yasui, T., et al. (2008). Estradiol suppresses NMU mRNA expression during sexual maturation in the female rat pituitary. Int. J. Dev. Neurosci. 26,381-384.
90. Steel, J. H., Van Noorden, S., Ballesta, J., Gibson, S. J., Ghatei, M. A., Burrin, J., et al. (1988). Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus, and in 30 human pituitary and extrapituitary tumors. Endocrinology 122, 270-282.
91. Szekeres, P. G., Muir, A. I., Spinage, L. D., Miller, J. E., Butler, S. I., Smith, A., et al. (2000). Neuromedin U is a potent agonist at the orphan G protein-coupled receptor FM3. J. Biol. Chem. 275, 20247-20250.
92. Tachibana, T., Matsuda, K., Khan, M. S., Ueda, H., and Cline, M. A. (2010). Feeding and drinking response following central administration of neuromedin S in chicks. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 157, 63-67.
93. Tan, C. P., McKee, K. K., Liu, Q. Y., Palyha, O. C., Feighner, S. D., Hreniuk, D. L., et al. (1998). Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secreta-gogue and neurotensin receptors. Genomics 52, 223-229.
94. Ten Donkelaar, H. J. (1998). "Urodeles," in The Central Nervous System of Vertebrates, Vol. 1, eds R. Nieuwenhuys, H. J. Donkelaar, and C. Nicholson (Berlin: Springer Verlag), 1045-1149.
95. Thompson, E. L., Murphy, K. G., Todd, J. F., Martin, N. M., Small, C. J., Ghatei, M. A., et al. (2004). Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. Biochem. Biophys. Res. Commun. 323, 65-71.
96. Trejter, M., Guidolin, D., Nowak, M., Macchi, V., Majchrzak, M., De Caro, R., et al. (2009). Neuromedin U enhances proliferation of ACTH-stimulated adrenocortical cells in the rat. Int. J. Mol. Med. 23, 99-104.
97. Trejter, M., Neri, G., Rucinski, M., Majchrzak, M., Nussdorfer, G. G., and Malendowicz, L. K. (2008). Neuromedin-U stim ulatesenucleation-induced adrenocortical regeneration in the rat. Int. J. Mol. Med. 21, 683-687.
98. Vigo, E., Roa, J., López, M., Castellano, J. M., Fernandez-Fernandez, R., Navarro, V. M., et al. (2007). Neuromedin s as novel putative regulator of luteinizinghormone secretion. Endocrinology 148, 813-823.
99. Wren, A. M., Small, C. J., Abbott, C. R., Jethwa, P. H., Kennedy, A. R., Murphy, K. G., et al. (2002). Hypothalamic actions of neuromedin U. Endocrinology 143, 4227-4234.
100. Yayou, K., Kitagawa, S., Ito, S., Kasuya, E., and Sutoh, M. (2009). Effects of intracerebroventricular administration of neuromedin U or neuromedin S in steers. Gen. Comp. Endocrinol. 163, 324-328.
101. Yokota, M., Ozaki, Y., Sakamoto, F., Yamada, S., Saito, J., Fujihara, H., et al. (2004). Fos expression in CRF-containing neurons in the rat paraventricular nucleus after central administration of neuromedin U. Stress 7, 109-112.
102. Zeng, H., Gragerov, A., Hohmann, J. G., Pavlova, M. N., Schimpf, B. A., Xu, H., et al. (2006). Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding. Mol. Cell. Biol. 26, 9352-9363.
103. Ziolkowska, A., Macchi, C., Trejter, M., Rucinski, M., Nowak, M., Nussdorfer, G. G., et al. (2008). Effects of neuromedin-U on immature rat adrenocortical cells: in vitro and in vivo studies. Int. J. Mol. Med. 21,303-307.